Skeletal metastases from breast cancer: Imaging with nuclear medicine

被引：37

作者：

Cook, GJR ^{[1
]}

Fogelman, I ^{[1
]}

机构：

[1] Guys Hosp, Dept Nucl Med, London SE1 9RT, England

来源：

SEMINARS IN NUCLEAR MEDICINE | 1999年 / 29卷 / 01期

关键词：

D O I：

10.1016/S0001-2998(99)80031-2

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Breast cancer is a disease that commonly metastasizes to bone, increasing morbidity, mortality, and health service costs. The 99m technetium (Tc-99m) diphosphonate bone scan historically has played a significant part in the evaluation of skeletal disease and continues to be one of the most clinically utilized investigations in the staging and follow up of breast cancer patients. More tumor-specific radiopharmaceuticals are now being evaluated and, in particular, 18-fluoro-2-deoxyglucose positron emission tomography ((18)FDG PET) may have a greater role in this disease in the future. Copyright (C) 1999 by W.B. Saunders Company.

引用

页码：69 / 79

页数：11

共 65 条

[31]

GALASKO CSB, 1984, RADIONUCLIDE SCINTIG, P65

[32] EFFICACY OF PREOPERATIVE AND POSTOPERATIVE BONE SCANNING IN MANAGEMENT OF BREAST CARCINOMA [J].